Achilles Therapeutics plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SYNCONA PORTFOLIO LTD | 02/06/2025 | 11.09 M | $12.64 M | 0.00% | 27.42% |
| BML CAPITAL MANAGEMENT, LLC | 02/07/2025 | 4.10 M | $4.67 M | 0.00% | 10.14% |
| FCPM III SERVICES B.V. | 02/14/2025 | 2.39 M | $2.75 M | 0.00% | 5.91% |
| REDMILE GROUP, LLC | 02/14/2025 | 1.61 M | $1.83 M | 0.00% | 3.98% |
| VESTAL POINT CAPITAL, LP | 02/14/2025 | 1.50 M | $1.71 M | 0.00% | 3.71% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 1.44 M | $1.64 M | -0.14% | 3.56% |
| SIREN, L.L.C. | 02/14/2025 | 755.38 K | $861.13 K | 0.00% | 1.87% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 547.23 K | $623.85 K | -14.24% | 1.35% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 418.44 K | $477.02 K | -0.49% | 1.04% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 191.83 K | $218.00 K | -23.52% | 0.47% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 61.64 K | $70.27 K | 190.07% | 0.15% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 50.19 K | $57.22 K | 100.00% | 0.12% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 34.20 K | $38.99 K | 52.68% | 0.08% |
| MORGAN STANLEY | 05/15/2025 | 33.73 K | $38.45 K | 105.29% | 0.08% |
| XTX TOPCO LTD | 02/13/2025 | 26.82 K | $30.58 K | 100.00% | 0.07% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 21.59 K | $24.61 K | 0.00% | 0.05% |
| CITADEL ADVISORS LLC | 02/14/2025 | 15.80 K | $18.01 K | 100.00% | 0.04% |
| BRAVE ASSET MANAGEMENT INC | 01/14/2025 | 10.00 K | $11.40 K | 0.00% | 0.02% |
| RHUMBLINE ADVISERS | 05/29/2025 | 4.48 K | $5.11 K | 0.00% | 0.01% |
| 02/06/2025 | 322 | $367 | 100.00% | 0.00% | |
| JPMORGAN CHASE & CO | 02/12/2025 | 137 | $156 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ARCADIA INVESTMENT MANAGEMENT CORP/MI | 02/03/2025 | 0 | $0 | -100.00% | 0.00% |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| BAADER BANK AKTIENGESELLSCHAFT | 01/23/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Achilles Therapeutics plc institutional Ownership - FAQ's
During the previous two years, 18 institutional investors and hedge funds held shares of Achilles Therapeutics plc. The most heavily invested institutionals were:
TWO SIGMA ADVISERS, LP: 0
BOOTHBAY FUND MANAGEMENT, LLC: 0
JPMORGAN CHASE & CO: 0
BNP PARIBAS ARBITRAGE, SNC: 0
FCPM III SERVICES B.V.: 0
MORGAN STANLEY: 0
60.10% of Achilles Therapeutics plc stock is owned by institutional investors.